Form 4: Generation Bio Co. Executive Matthew Stanton Reports Stock Transactions
SEC Form 4
Matthew Stanton, Chief Scientific Officer of Generation Bio Co., reports the vesting and subsequent disposal of shares related to restricted stock units.
Summary
- On July 15, 2024, Matthew Stanton, the Chief Scientific Officer of Generation Bio Co., vested 1,674 shares of common stock from restricted stock units.
- Following the vesting, Stanton disposed of 492 shares to cover tax obligations at a price of $2.93 per share.
- After these transactions, Stanton directly owns 246,137 shares of Generation Bio Co. common stock and 16,733 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by an insider, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the actions of company executives regarding their holdings in the company's stock.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent a small fraction of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| January 20, 2023 | Reporting person was granted 26,775 restricted stock units. |
| January 15, 2024 | 25% of the restricted stock units granted on January 20, 2023 vested. |
| July 15, 2024 | 1,674 restricted stock units vested and 492 shares were disposed of for tax obligations. |
| July 17, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.